共 29 条
[1]
[2]
Prognostic value of pretreatment levels of tumor markers for hepatocellular carcinoma on survival after curative treatment of patients with HCC[J] Hidenori Toyoda;Takashi Kumada;Yuji Kaneoka;Yukio Osaki;Toru Kimura;Akira Arimoto;Hiroko Oka;Osamu Yamazaki;Takao Manabe;Fumihiro Urano;Hobyung Chung;Masatoshi Kudo;Takashi Matsunaga Journal of Hepatology 2008,
[3]
Improving the comparability of immunoassays for prostate-specific antigen (PSA): Progress and problems[J] Catharine M. Sturgeon;Andrew R. Ellis Clinica Chimica Acta 2007,
[4]
Assessment of intra‐individual variation in prostate‐specific antigen levels in a biennial randomized prostate cancer screening program in Sweden[J] LailaBruun;CharlotteBecker;JonasHugosson;HansLilja;AndersChristensson Prostate 2005,
[5]
The relation of Helicobacter pylori to gastric adenocarcinoma and lymphoma: pathophysiology; epidemiology; screening; clinical presentation; treatment; and prevention[J] Barry J. Marshall;Helen M. Windsor Medical Clinics of North America 2005,
[6]
Carcinoembryonic Antigen in the Staging and Follow-up of Patients with Colorectal Cancer[J] Mitchell J. Goldstein;Edith Peterson Mitchell Cancer Investigation 2005,
[7]
Colon Cancer Screening Guidelines 2005: The Fecal Occult Blood Test Option Has Become a Better FIT[J] James E. Allison Gastroenterology 2005,
[8]
Meta-analysis on the validity of pepsinogen test for gastric carcinoma; dysplasia or chronic atrophic gastritis screening[J] DinisRibeiro M;Yamaki G;Miki K;CostaPereira A;Matsukawa M;Kurihara M Journal of Medical Screening 2004,
[9]
Diagnosis and staging of hepatocellular carcinoma[J] Jayant A. Talwalkar;Gregory J. Gores Gastroenterology 2004,
[10]
Laboratory variables and stratification of metastatic colorectal cancer patients: recommendations for therapeutic trials and for clinical practice guidelines[J] Joseph Watine;Bruno Friedberg Clinica Chimica Acta 2004,

